<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Caspian Journal of Internal Medicine</title>
<title_fa></title_fa>
<short_title>Caspian J Intern Med</short_title>
<subject>Medical Sciences</subject>
<web_url>http://caspjim.com</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-6164</journal_id_issn>
<journal_id_issn_online>2008-6172</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.22088/cjim</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1403</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2025</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>16</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Decreased plasma levels of sestrin-1 and sestrin-2 in patients with coronary artery disease and their association 
with the disease severity</title>
	<subject_fa>Biochimestry</subject_fa>
	<subject>Biochimestry</subject>
	<content_type_fa>Original Article</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;&lt;span style=&quot;font-size:14px&quot;&gt;&lt;span style=&quot;font-family:Times New Roman&quot;&gt;&lt;strong&gt;&lt;em&gt;&lt;span style=&quot;color:blue&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;Background&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;em&gt;&lt;span style=&quot;color:blue&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt; &lt;/span&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;Oxidative stress has been well established to participate in the pathology of coronary artery disease (CAD). Sestrin family of proteins have recently emerged as important suppressors of oxidative stress. However, only few studies have reported the levels of sestrins and their clinical significance in CAD patients.&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;strong&gt;&lt;em&gt;&lt;span style=&quot;color:blue&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;Methods:&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt; &lt;/span&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;Participants were ninety patients referred to the&amp;nbsp;cardiac angiography&amp;nbsp;unit for cardiac angiography. Thirty-two subjects were diagnosed as having stable CAD, twenty patients had unstable CAD and thirty-eight subjects had no CAD. All patients underwent angiography and the severity of coronary stenosis was calculated by modified Gensini score.&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt; The levels of glucose, triglyceride, total cholesterol, HDL, LDL, hs-CRP and hematological parameters were determined in the fasting blood samples &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;by routine methods.&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;color:black&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt; Plasma levels of sestrin-1 and sestrin-2 were measured by ELISA. &lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;strong&gt;&lt;em&gt;&lt;span style=&quot;color:blue&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;Results&lt;/span&gt;&lt;span style=&quot;background-color:yellow&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt; &lt;/span&gt;&lt;span style=&quot;background-color:yellow&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;Although the plasma levels of sestrin-1 were significantly lower in both case groups compared with the control group&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;background-color:yellow&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;, &lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;background-color:yellow&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;there were no significant differences in sestrin-1 levels between the two patient groups. The levels of sestrin-2 were also significantly lower in both CAD groups than in controls, but no significant difference was found between stable and unstable patients. In the whole study subjects,&lt;/span&gt;&lt;/span&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt; plasma sestrin-1 and sestrin-2 showed negative correlation with the coronary artery score. By multivariate analysis only sestrin-2 levels were significantly related to CAD severity. &lt;/span&gt;&lt;br&gt;
&lt;strong&gt;&lt;em&gt;&lt;span style=&quot;color:blue&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;Conclusion&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;/strong&gt;&lt;em&gt;&lt;span style=&quot;color:blue&quot;&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;:&lt;/span&gt;&lt;/span&gt;&lt;/em&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt; &lt;/span&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;Our findings showed a negative association of sestrin levels and the coronary stenosis severity&lt;/span&gt;&lt;span style=&quot;background-color:#ffffff&quot;&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&amp;nbsp;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Coronary artery disease, sestrins, Sesn1 protein, Sesn3 protein, coronary stenosis.</keyword>
	<start_page>255</start_page>
	<end_page>262</end_page>
	<web_url>http://caspjim.com/browse.php?a_code=A-10-3219-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Somayeh</first_name>
	<middle_name></middle_name>
	<last_name>Heidar Beygi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>sbeygi276@gmail.com</email>
	<code>100319475328460052215</code>
	<orcid>0009-0009-9186-2338</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Gholamreza</first_name>
	<middle_name></middle_name>
	<last_name>Namazi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>namazimajid@gmail.com</email>
	<code>100319475328460052216</code>
	<orcid>100319475328460052216</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Parastoo</first_name>
	<middle_name></middle_name>
	<last_name>Asa</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>parastoo.asa@gmail.com</email>
	<code>100319475328460052217</code>
	<orcid>100319475328460052217</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, I.R. Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Raziyeh</first_name>
	<middle_name></middle_name>
	<last_name>Salami</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>raziyehsalami@gmail.com</email>
	<code>100319475328460052218</code>
	<orcid>100319475328460052218</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Cardiology, School of Medicine, Kashan University of Medical Sciences, Kashan, Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Alireza</first_name>
	<middle_name></middle_name>
	<last_name>Mafi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>armafi.m@gmail.com</email>
	<code>100319475328460052219</code>
	<orcid>100319475328460052219</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Clinical Biochemistry, School of Medicine, Kashan University of Medical Sciences, Kashan. I.R. Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Fariba</first_name>
	<middle_name></middle_name>
	<last_name>Raygan</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>rayegan.fariba@gmail.com</email>
	<code>100319475328460052220</code>
	<orcid>100319475328460052220</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Cardiology, School of Medicine, Kashan University of Medical Sciences, Kashan, I.R. Iran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
